NM_014289.4:c.1416C>T
Variant names:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2
The NM_014289.4(CAPN6):c.1416C>T(p.Thr472Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00129 in 1,207,994 control chromosomes in the GnomAD database, including 21 homozygotes. There are 417 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0070 ( 9 hom., 207 hem., cov: 23)
Exomes 𝑓: 0.00071 ( 12 hom. 210 hem. )
Consequence
CAPN6
NM_014289.4 synonymous
NM_014289.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.45
Genes affected
CAPN6 (HGNC:1483): (calpain 6) Calpains are ubiquitous, well-conserved family of calcium-dependent, cysteine proteases. The calpain proteins are heterodimers consisting of an invariant small subunit and variable large subunits. The large subunit possesses a cysteine protease domain, and both subunits possess calcium-binding domains. Calpains have been implicated in neurodegenerative processes, as their activation can be triggered by calcium influx and oxidative stress. The protein encoded by this gene is highly expressed in the placenta. Its C-terminal region lacks any homology to the calmodulin-like domain of other calpains. The protein lacks critical active site residues and thus is suggested to be proteolytically inactive. The protein may play a role in tumor formation by inhibiting apoptosis and promoting angiogenesis. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant X-111248637-G-A is Benign according to our data. Variant chrX-111248637-G-A is described in ClinVar as [Benign]. Clinvar id is 777822.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.45 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00702 (785/111838) while in subpopulation AFR AF= 0.0244 (751/30785). AF 95% confidence interval is 0.0229. There are 9 homozygotes in gnomad4. There are 207 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00701 AC: 784AN: 111785Hom.: 9 Cov.: 23 AF XY: 0.00610 AC XY: 207AN XY: 33953
GnomAD3 genomes
AF:
AC:
784
AN:
111785
Hom.:
Cov.:
23
AF XY:
AC XY:
207
AN XY:
33953
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00177 AC: 325AN: 183283Hom.: 6 AF XY: 0.00109 AC XY: 74AN XY: 67739
GnomAD3 exomes
AF:
AC:
325
AN:
183283
Hom.:
AF XY:
AC XY:
74
AN XY:
67739
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000709 AC: 777AN: 1096156Hom.: 12 Cov.: 30 AF XY: 0.000580 AC XY: 210AN XY: 362322
GnomAD4 exome
AF:
AC:
777
AN:
1096156
Hom.:
Cov.:
30
AF XY:
AC XY:
210
AN XY:
362322
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00702 AC: 785AN: 111838Hom.: 9 Cov.: 23 AF XY: 0.00609 AC XY: 207AN XY: 34016
GnomAD4 genome
AF:
AC:
785
AN:
111838
Hom.:
Cov.:
23
AF XY:
AC XY:
207
AN XY:
34016
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 14, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at